40 chronic schizophrenic patients had their psychophysiological responses to 1 of 2 tension-arousing movies recorded. Following assignment to drug (thiordizane) or placebo status for 1 wk. they were retested on a similar film. The results were that the drug Ss showed a decrease in skin resistance and heart rate but not finger-pulse volume over their responses to the 1st showing while the placebo group showed opposite trends. Interview data collected after the films indicated no correlation between the autonomic changes and plot comprehension. Pilot work on word-association test responses indicates that the drug group showed a decrease while the placebo group showed an increase in idiosyncratic responses.
Despite repeated demonstrations with acute (Psychopharmacology Study Center Group, 1964) and chronic (Casey, Bennett, Lindley, Hollister, Gordon, & Springer, 1960) schizophrenics that tranquilizing drugs of the phenothiazine derivative group are associated with marked behavioral change, the exact manner in which the drugs produce these changes is not clearly understood. One hypothesis which has received general acceptance is that the behavioral change is secondary to a reduction of autonomic responses to anxiety-producing stimuli. Despite the general acceptance of this hypothesis, surprisingly few attempts have been made to test it experimentally on schizophrenic patients.
In contrast to the plethora of studies on behavioral effects of tranquilizing drugs, only a small number of studies have been reported on the effects of drugs on the autonomic nervous system response in schizophrenia. Par-1 This study was supported by Grants MH 04720 and 08744 from the National Institute of Mental Health and by the Veterans Administration Center in Los Angeles through staff and facilities support. The authors would like to express their appreciation to Carol April, Paul Lewinsohn, Linda Miller, Granville Murphy, Marianne Osborn, and Charles Swearingen who assisted in data collection and analysis. Special thanks are also due the Health Sciences Computing Facilities at UCLA for computer time, ticularly lacking has been research relating autonomic responses to emotionally arousing stimuli to drug status. The research which has been done (e.g., Mitchell & Zax, 19S9) has suggested a reduction in autonomic responsiveness as a function of drug status; however, this research has been difficult in its interpretation for the following two reasons. First, a single autonomic response indicator (typically skin resistance) was used. This made it difficult to determine whether the reduction in responsiveness noted was entirely local (drying of the skin of the palm) or part of a general attenuation in autonomic nervous system activity. Second, the stimuli used were not of a class ordinarily believed highly potent in arousing anxiety in the schizophrenic (aloud tone). Clinical evidence (Arieti, 19SS) suggests that the kind of stimuli which elicit anxiety in the schizophrenic are personal-social in nature, involving close interpersonal relationships, sexual cues, aggression, and self-assertive behavior. In the present study, the first of these difficulties was countered by the use of multiple measures of autonomic activity obtained concurrently to determine the generality of the drug effect. With respect to the second difficulty, it was felt that the effects of tranquilizing drugs could be best estimated using stimuli which were likely to maximize involvement and which dealt with 335 thematic materials likely to mobilize anxiety in the schizophrenic. Therefore, tensionarousing films were selected as the stimuli, with psychophysiological responses to the films as the dependent variables. The basic hypothesis was that all indexes of autonomic reactivity recorded would show attenuation under the drug condition when compared to the individual's reactivity to a similar stimulus under the placebo condition.
METHOD
Subjects. There were 40 chronic schizophrenics selected at random from the wards of the Brentwood Veterans Administration Hospital who served as subjects (Ss). The Ss were drawn from one ward at a time, assigned alternately to a drug or placebo group and, when all available patients had been selected from that ward, Ss were selected consecutively from another available ward. This procedure was continued until 21 drug 5s 2 and 19 placebo Ss were run in the experiment.
Basic Design of the Experiment. The experiment involved basically an off-on design. Each patient was withdrawn from his current medication and placed on a placebo for a period of time called the withdrawal period. During the withdrawal period, urine samples were collected upon arising three times a week. Samples were checked by a test (Forrest, Forrest, & Mason, 1961) for the presence of phenothiazine in the urine.
3 While this test is much less sensitive to the presence of thioridazine (Mellaril), it still provided a crude index of the amount of drug in the urine. A score of 0, or +1 following a 0, on this colorimetric test was identified as a "negative" reading, while a score of +2 or more (+6 maximum possible) was identified as a "positive" reading for purposes of this study.
Before beginning the experimental procedures, an S was required to have been on placebo for a minimum of 2 weeks and also to have shown two successive phenothiazine-negative urine tests (to assure excretion of prestudy medication). The mean time between drug withdrawal and the first experimental session was 18.3 days for the total patient sample. It should be recognized that the absence of phenothiazine in the urine does not indicate a complete absence of the drug in the body (Forrest et al., 1961) . Clinical studies (Caffey, Forrest, Frank, & Klett, 1963) indicate that regressions in clinical behavior continue to occur for some time after the laboratory procedures fail to detect any substantial amount of phenothiazine. This strongly suggests that 2 The authors' original plan was for 20 drug and 20 placebo patients but due to a clerical error the assignment ended up 21 to 19. 8 The authors are indebted to Donald Parkhurst, Chief, Clinical Laboratory, Brentwood Veterans Administration Hospital and his staff for running the phenothiazine urine tests. a certain percentage of the drug is retained long after active drug withdrawal. Thus, Ss at the time of first testing could be more accurately characterized as being at a minimal, rather than at a nondrug level. The 2-week minimum period between withdrawal and testing represented essentially a compromise between the ideal experiment and certain biases which would have been introduced by a longer withdrawal period. Previous research in our laboratory has indicated that when an experiment extends for more than a 30-day period, a substantial loss in Ss occurs through discharge or regression to a more acute state which requires readministration of an active drug. Further, Chapman (1963) has reported that patients who show this behavioral disorganization earliest represent a selective group in terms of manifesting a more severe thought disorder, whose absence from the sample introduces limitations in the generality of drug-study findings. Therefore, the advantage of a minimal loss in the S sample (actually no patients were lost) was chosen over the disadvantage of testing patients with less than complete drug withdrawal.
Drugs. The experimental medication in this study was thioridazine (Mellaril: Sandoz).
4 This medication was chosen as being fairly typical of the more commonly used phenothiazine derivatives. It resembles chlorpromazine (Thorazine: Smith, Kline & French) in the clinical indications and in its clinical effects. However, it does not customarily require additional medication for the control of extrapyramidal symptoms (pseudoparkinsonism), which would introduce added complications in a psychophysiological drug study.
The drug was administered in 100-milligram tablets. The placebo medication was provided by the manufacturer and was identical in appearance and taste to the active medication. The initial dosage was one tablet four times per day. The ward physician was allowed to raise or lower this dosage within moderate limits according to apparent clinical requirements, but this rarely occurred. The drug was identified by a numerical code. The ward physician, nurses, and research assistants on the project who actually saw the patients did not know which was active and which was placebo medication.
First Experimental Session. When S had satisfied the urine test criterion and at least 2 weeks had passed from the initiation of active withdrawal, he was asked to report to the psychology laboratory (which was located adjacent to the hospital EEC laboratory). The S was told that the experimenters (£s) were going to take some measures "to see how his treatment was affecting him." Following this, the patient was taken into a sound-attenuated 9 X 9 foot air-conditioned chamber, 5 shown the psychophysiological leads, and given a brief introduction to what was measured by each lead. The S was seated in an easy chair, pickups were attached and S was told to relax for a 10-minute period, after which a film would appear on the screen, which he was requested to watch. The E then left the room and the 10-minute adaptation period was begun which was designed to acclimatize the patient to the attachments and experimental room. Following this period, during which psychophysiological measures were recorded continuously, the projector was started and a 24-minute sound film was run. After the film, the patient was unhooked from the equipment and interviewed concerning his comprehension and reaction to the film. He was taken to an adjoining room where other psychological procedures, including a word-association test and, where possible, The Perceptual Defense Battery (Goldstein, Jones, & Kinder, 1964) , were carried out.
Second Test. Procedures for the second experimental session, when 5 viewed the alternate film, were identical to those of the first session. The 5s were run on the second testing day at the same time of day that they were run on first testing. Half of the 5s were run in the morning and half in the afternoon.
Movies Used. The films used in the experiment were both made by Alfred Hitchcock as television programs. 6 The films were presented in counterbalanced order with one half of the Ss receiving one film first and the other half, the other film first.
The two films were titled Man From the South (MS) and No Pain (NP).
The basic plot of MS involves a man who has bet his pinky finger that his cigarette lighter will fire successfully 10 times in a row. The film builds steadily in tension to a scene in which a somewhat sadistic gambler stands with a meat cleaver poised over the bound finger of the hero, who is going through the sequence of lighting his lighter. The film, which was judged quite arousing by all who saw it, dealt with stimuli likely to be threatening to the schizophrenic such as aggression, mutilation, and possibly castration anxiety. The plot of NP dealt with a completely paralyzed man who was required to spend all of his time in an iron lung, totally dependent upon his vivacious young wife. As the story develops, there are a number of arousing scenes, one a flashback of a sexual nature in which the man is shown as a vigorous and virile person making love to his wife; the film then returns to the man paralyzed and impotent. Later in the film, it becomes obvious that the wife is trying to kill her husband and there is uncertainty as to whether or when the wife will permanently disconnect the iron lung. Again, this film presented a number of themes potentially disturbing to the schizophrenic such as infidelity of the wife, sexual arousal, and the contrast between early masculine virility and later impotence and helpless-ness. Fortunately, analyses of psychophysiological responses of the total patient groups indicated no difference between movies in average level of reactivity so that they could be treated as relatively equivalent tests in their arousal potential.
Assignment to Drug or Placebo Status. Prior to the first movie viewing, Ss were assigned alternately to the Drug or Placebo groups. Following the first movie test session, the placebo group continued to receive the same placebo medication administered during the withdrawal period. Within 12 hours of the first test session, the drug group began to receive the active drug medication.
During the period following the assignment to drug or placebo status, the phenothiazine urine test was done three times a week on alternate days as a check on whether patients were truly ingesting the pills. Second testing occurred when a minimum of 7 days had elapsed. In addition, two consecutive positive urine tests were required for retesting in the drug groups and two consecutive negative tests were required for retesting the placebo group. As indicated previously, the range of scores obtained on this test with this particular phenothiazine was very narrow; however, the readings did correlate with drug or placebo status such that there was virtually no overlap between the groups on the second testing day. The mean number of days between first and second testing was 8.8 days.
Psychophysiological Measures Recorded. Throughout the 10-minute rest period and the 24-minute film period, the following measures were continuously recorded by an Offner Type R Dynograph recorder: (a) Skin resistance with palm-to-palm attachment, using cup-type (2 centimeters in diameter) zinc electrodes, zinc sulfate paste, and a 40-microampere Darrow-type bridge 7 with DC coupling to the polygraph recorder. (6) Heart rate, with electrodes attached to each side of the chest using a cardiotachometer (see Footnote 7) with AC coupling to the polygraph recorder, (c) Finger-Pulse Volume using a finger cup on the left index finger with a closed pneumatic connection to a plethysmograph transducer (see Footnote 7) with AC coupling to the polygraph recorder.
RESULTS
The basic design of this study required some comparison of indexes of psychophysiological reactivity for the two film viewings. This required that for each psychophysiological variable some summary measures be devised which could reflect the important parameters of a 24-minute reaction period; since these summary measures varied for each variable, the results will be discussed separately for each psychophysiological variable.
Skin Resistance, Admittedly, there are an infinite number of indexes which can be derived from a continuously recorded skinresistance curve. There was particular interest in two dimensions of the skin-resistance response, the long-term shifts in skin-resistance level upward or downward from a basal level and the relatively discrete changes (GSRs) occurring at critical scenes in the movie. The independence of these dimensions is strongly supported by Spiesman, Osborn, and Lazarus (1961) in their parametric study of skin-resistance measures. Two measures of long-range changes were of particular interest: (a) The net activation-relaxation score of the individual, and (b) the total range of response from maximum to minimum tension level. With regard to the former, it is obvious that during response to a complex stimulus such as a film there are two general processes operating, one involving the gradual adaptation of 5 to the film viewing experience which should be accompanied by a rising skin resistance and a second process of reactivity to specific tension-arousing scenes which should be accompanied by a declining skin resistance. Therefore there was interest in whether the drops in skin resistance (activation) were greater than or equal to the rises in skin resistance above resting level (relaxation) due to long-range adaptation. The mean level of response was not chosen as an index of arousal despite its high loading on Cluster II in the Spiesman et al. (1961) research as it is too insensitive a measure for a study of this sort. It provides a crude index of stress response when two stimuli widely different in tension potential are compared, but is not sufficiently sensitive to reveal individual differences in reactivity, a conclusion also reached by the Lazarus group in later papers (Spiesman, Lazarus, Mordkoff, & Davison, 1964) .
The skin-resistance curves for the 24-minute film period were read for the following parameters and converted to log conductance units: (a) Beginning conductance: this was the highest conductance appearing during the 30 seconds following the start of the projector and appearance of the film on the screen (orienting response to projector or onset Of film). This measure, rather than one of the resting scores, was used as a basal index for correcting the later measures as it was noted that Ss frequently failed to recover fully from their orienting response such that this became the basal level of an alerted organism against which all later changes to emotional stimuli could be more appropriately compared, (b) Highest conductance during the film. This reflected the point of maximum activation during the film following the initial 30-second interval, (c) Lowest conductance during the film. This reflected the point of maximum relaxation during the film, (d) The average of the three largest GSRs within a 10-second period occurring at any three points during the course of the film. Certain summary indexes were derived from a, b, and c measures as follows:
1. Net Activation-Relaxation: A measure which reflected whether S showed a greater rise or drop in conductance from his basal level during the course of the film. This score was computed as follows: (highest conductance -beginning level) minus (beginning level -lowest conductance). This net score was computed such that a plus score reflected greater activation than relaxation while a minus score had the opposite meaning.
2. Total range of skin-conductance change. This measure reflected the total range of skinconductance change regardless of the nature of the change. This was computed as follows: (highest conductance -beginning) plus (beginning -lowest conductance).
3. Average of three largest GSRs which was described above.
The means for the three indexes for first and second testing are presented in Table 1 . It can be seen in Table 1 that the changes from first to second viewings for drug and placebo groups vary with the index used. The measure of net activation-relaxation (highest -beginning) -(beginning -lowest) fails to indicate any significant effect due to drug status; however, the total range and the average of the three largest GSRs indicate a diminished responsiveness for the drug group and unexpectedly an enhanced responsiveness for the placebo group on the second testing.
The skin-conductance data were analyzed by analysis of covariance in which the initial testing score was used as a covariate to adjust the second testing score. However, while all Fs reported in Table 1 are from covariance analyses, the means represented there are not adjusted means but are the actual means for each session. The drug group and the placebo group do not differ significantly on total range and average of three largest GSRs on the first testing, indicating that the difference between the groups appears only after the active drug agent has been introduced. Thus, there is a dampening of response in the drug group on two out of three measures and slightly greater responsiveness in the placebo group.
Covariance analysis was also done in a manner which permitted analysis of order effects (MS or NP on first showing). Order of film presentation was not significant for each of our three indexes of skin-resistance response (Fs -0.14, 0.30, and 1.33, respectively for measures as listed in Table 1) , and the interaction of order of film presentation and drug status (Fs = 0.18, 0.04, 0.8 for the three indexes in Table 1 ) also was not significant. Thus, the reduction in responsiveness noted under the drug condition was independent of the content of the film viewed in the second session.
Heart-Rate Data. The data for heart rate were read and analyzed in a different fashion from skin resistance, Research using films (Malmstrom, 1964) indicates that heart rate does not follow the events of a film with nearly the precision of skin resistance. The various automatic homeostatic mechanisms which operate to bring deviations back into normal range as well as the cyclical relationship to respiration interact with heart-rate changes to a film to produce a given record of response. Therefore, the type of measures used for skin resistance was not considered appropriate for heart rate. Instead, following Malmstrom's suggestion, a method of moving averages was used to identify the period of maximum heart-rate acceleration. This method was used to average out short-run homeostatic and respiratory cycles. This type of measure is not directly comparable to the measures used for skin resistance but appears to be more sensitive to the cyclical nature of the heart-rate response, a quality not present in skin resistance.
Six 1-minute periods were chosen so as to span six potentially emotional scenes in each movie such that each period began 30 seconds prior to the emotional scene and continued into the high point of the scene. Fortunately, the two movies were so constructed that the same six 1-minute time intervals could be used in reading records for both films. This means that the period of time from onset of the projector was approximately the same for each 1-minute period read for MS and NP. Within each 1-minute segment, heart rate was read continuously. The data obtained were then treated as a continuous series, and moving averages were computed to smooth out irregularities in the time series. The moving averages were computed by taking consecutive averages of beats per minute for each set of 30 adjacent beats (the means of Beats 1-30, 2-31, 3-32, 4-33, etc.). The largest moving average obtained was treated as a stable index of the individual's peak response of heart-rate acceleration during the six 1-minute series and was used as a summary index of peak reactivity to the film.
Adjustment of these data for basal level is particularly critical in a study of this type as the phenothiazine drugs have been noted to cause tachycardia in a substantial number of patients. Thus, any estimates of variation in reactivity would have to be made against variations in basal level from Session 1 to Session 2. The choice of basal or initial level is not a simple matter. While the restinglevel data prior to the onset of the film would be a conventional analogue of the typical prestimulus measure, it was obvious from postsession interviews that many schizophrenics were extremely fearful during the resting period and apparently apprehensive that something painful was about to happen to them. Many doubted that a film would be shown and were distrustful on this score. Frequently, following the onset of the projector, a brief heart-rate acceleration was followed by a continuous decline in the average heart-rate level. Bursts of acceleration could be seen from this declining level, but frequently the overall trend was descending to a level lower than the "resting" level. Thus, it was uncertain whether the prestimulus level or the lowest level achieved during the film was the more appropriate basal level for adjusting the reactivity scores. Since no rational basis existed for choosing between them, the heart-rate data were analyzed twice, once for each basal level. The correction for basal level used was that recommended by Lacey (1959) in which S's corrected score is his deviation from the regression line of basal level on reactivity. The scores generated are deviation scores which are plus or minus in sign depending on whether S is more or less reactive than would be predicted on the basis of his basal level. A corrected score was computed for each S for each experimental session and the difference between the two scores was obtained such that a plus score indicated greater reactivity on the second showing and a minus score, less reactivity. Of the original sample of 40 5s only 34 provided two sets of heart-rate data which were deemed satisfactory for analysis. The mean difference scores in which the premovie resting level was used as the basal level to predict reactivity were -3.OS for the drug group and +0.93 for the placebo group. Analysis of variance of these difference scores revealed a between-groups F of 5. 01 (df -1/32) which is significant at the .05 level. The mean difference scores where the lowest level during the film was used as the basal level to adjust reactivity were -5.13 for the drug group and +1.13 for the placebo group. The F from the analysis of variance for these difference scores was 6.99 (rf/=l/32), which is also significant at the .05 level. Thus, the drug group shows less reactivity in heart rate on the second showing while the placebo group, as in the findings reported above for skin-resistance data, shows slightly greater reactivity on the second showing, independent of the basal measure used. Once again we failed to find a significant effect for type of film or the interaction between film order and drug status.
The data were also analyzed using a measure of variability in heart rate, a dimension found independent of mean level and fastest period by the Spiesman et al. (1961) cluster analysis. Using the previously cited six 1-minute continuously read data, standard deviations based on 430 beats were computed for each individual. Since a scatter plot failed to reveal a correlation with initial heart-rate level, the data were not corrected in any fashion. Once again the difference between first and second viewing was computed such that a minus equaled lowered reactivity on the second showing. The mean difference score for the drug group in standard deviation of heart rate was -1.50 and for the placebo group -0.07 (F = 4.18, p < .05, df = 1/32) which is statistically significant. Thus, the variability in heart rate in the drug group is less during the second film viewing and shows little or no changes in the placebo group, supporting the analysis of fastest moving average.
Finger-Pulse Volume Data. The Plethysmograph data were analyzed in a fashion somewhat analogous to the skin-resistance data. Three measures were used: (a) Beginning -Maximum constriction level during the film. For this measure, the beginning level was used as a predictor to adjust this difference score in obtaining a corrected Lacey score. (b) (Beginning -Maximum constriction level) + (Maximum dilation level -Beginning level) . This measure reflects the maximum range in finger-pulse volume during the film. Once again beginning level was used as a predictor to obtain corrected levels of the complex difference score. (c) The average 0} the three largest con-strictions during the film. A constriction was defined as a marked change in pulse amplitude within a 10-second period. The preconstriction level just prior to each individually selected constriction was used to obtain a corrected score for that constriction and the average of the three greatest corrected scores was then obtained for each S. All corrections of finger-pulse data used the Lacey (1959) procedure. Table 2 presents the mean difference score on each measure (second minus first film viewing). It can be seen in Table  2 that, while two of the three measures follow the pattern noted earlier for skin resistance and heart rate of lesser reactivity in the drug group and greater reactivity in the placebo group, none of the means differ reliably from each other. However, a more detailed analysis of the data is instructive here. Only 6 of the 17 drug patients showed greater reactivity on the second showing, while 12 of the 18 placebo 5s with usable plethysmograph records showed greater reactivity on the second showing. These frequencies would tend to support the general hypothesis. Furthermore, in each group the scores which go against the group trend are very large in magnitude and it is this phenomenon which increases the error term markedly and thereby reduces the level of significance of the results.
Exploratory Study of Drug Effects on Associative Processes. A supplementary aspect of the present study was an investigation of changes in the nature of word-association test responses in drug and placebo groups. It was hoped that a study of this class of response, so closely allied to thinking disorder in schizophrenic patients, would provide an index of changes in thought patterns which might accompany reduction in autonomic responsiveness. No causal hypothesis was entertained on the relationship between these two response systems as it was considered entirely possible that reduction in autonomic responsiveness could result from, cause, or be entirely independent of changes in thought patterns. The exploratory study was conducted on the final 20 patients run in the study. Each patient was administered a 50-item word-association test immediately following the first movie viewing and was readministered the same test following the second movie viewing. The test was scored according to a scoring system described elsewhere and involved two clusters of response categories located in that study, one cluster based on the temporal aspects of responses and a second category derived from measures of thinking and memory disturbance. The temporal scores were: (a) the number of fast reaction times; No. FRT (2 seconds or less); (b) the jnean reaction time of all 50 responses, XRT; (c) the variance in reaction time of all 50 responses, a 2 RT. The thinking and memory disturbance scores were: (a) the number of Distant responses (D). This category is described more fully in the earlier publication and refers to responses in which the associative connection between stimulus and response are remote but possess some logical connection; (b) Austistic responses (A), essentially a more severe form of the D response but one in which no logical connection between stimulus and response can be discerned by an external observer. An example of this category would be the stimulusresponse sequence, figkt-tree; (c) Number of memory disturbances (M). This score is based on the number of responses reproduced incorrectly on the second administration of the word-association test. (After completing the list the test was immediately administered a second time with instructions to 5 to give the same response as on the first administration.) The latter category of responses was found in a previous investigation to cor- a One placebo patient refused to take the test on the second administration reducing the placebo -ZV to 9.
b The D score is based on a weighting formula in which two classes of responses are considered, mildly distant and moderately distant, with the latter assigned twice the weight of the former. Thus, the D score can be larger than the number of stimulus words.
relate moderately in a negative direction with behavior ratings of social contact by aides and nurses on the ward, with high scores associated with poor social contact. The data were treated by analysis of covariance in which the first session score on a variable was used as a covariate for the second session scores. The adjusted means and standard deviations for each variable are presented in Table 3 . It can be seen in Table 3 that there is only one variable on which a significant shift in associative responses can be noted and that is A, the most severe form of idiosyncratic response. The drug group's adjusted mean is significantly lower than the placebo mean; in addition it is lower than its initial mean. The placebo group shows an increase in autistic associations above its initial mean. These results must be interpreted with caution as they are only derived from half of the total sample; yet, it is interesting to note a parallel to the psychophysiological results in that the drug group shows a reduction in this response class while the placebo group shows an increase in this same class.
DISCUSSION
The present results support the hypothesis that ingestion of a tranquilizing drug of the phenothiazine group is associated with a reduction in autonomic reactivity to an anxietylinked stimulus in schizophrenic patients. The fact that this trend is apparent at a significant level on two indexes of autonomic reactivity and shows a similar trend on the third suggests that the present findings are not the result of peripheral changes (e.g., skin dehydration) but are more likely due to a general dampening of autonomic nervous system responsiveness. While large variations in the amount of reduction in responsiveness can be noted among the patients, some reduction in skin resistance and heart-rate reactivity was noted for the great majority of drug patients, while an increase in reactivity or no change was noted for the large majority of placebo patients. One link in the chain of evidence which remains to be explored is the relationship between the magnitude of attenuation in autonomic reactivity in a drug patient and the degree of alteration in clinical behavior during a comparable period. It seems probable, but largely unproven, that correlations between these two systems of behavior should exist such that large reductions in autonomic reactivity accompany and possibly precede reductions in agitation on a clinical level.
The reduction in autonomic reactivity in the drug group raises some question of the mediating mechanism for this attenuation. Did some change in cognitive appraisal of threat take place as a result of the drug which inhibited emotional arousal or, have cognitive appraisals of events remained constant but the associated emotional response dampened in some fashion? As the experiment progressed, the theoretical importance of these points became clear, and some attempt was made in the final run of 21 patients (12 drug and 9 placebo) to obtain some index of S's comprehension of the specific events in the film. As mentioned earlier, each 5 was interviewed following each film viewing regarding his reaction to the film, but only on the final series of 21 5s was a systematic rating of response done. A S-point scale of comprehension 8 was constructed which scaled the events in the film in order of importance to plot comprehension. The events mentioned were listed under each scale point and 5's rating was the number of events clearly perceived according to his interview. The ratings were made by one of the research assistants who ran 5s through the movie viewing and who was also "blind" regarding 5s' drug status. On these ratings, the higher the score, the greater the comprehension of the plot. The mean ratings of comprehension for the drug 5s were: first time = 3.42, second time = 3.42. For the placebo 5s: first time = 3.33, second time = 3.11. None of the means differed significantly from each other. Thus, there is actually no difference in the two groups in their initial level of comprehension nor in their comprehension of the second film. These data, while drawn from only half of our sample, do suggest that the autonomic changes noted are not paralleled by systematic changes in the clarity of perception of events in the film. Thus, if the drug or placebo status is associated with some systematic shifts in cognitive appraisals, the shifts involve more subtle factors than comprehension of the plot as determined by the rough ratings used here. Accordingly, our limited data appear congruent with the analysis of Himwich (1960) of the effects of chlorpromazine administration on response to painful stimuli in the rabbit. He states when chlorpromazine is given, the reticular formation is blocked and no longer shows the alerting response. This inhibition of the reticular formation does not prevent impulses evoked by a painful stimulus from traversing the lemnisci and awareness is thus achieved by way of the cortical mechanisms. But the severity of the associated distressing emotional accompaniment of the stimulus is greatly mitigated [p. 65] .
The findings in the pilot study on association responses, if replicated on another sample, raise some interesting theoretical questions regarding the relationship between remote, idiosyncratic associations, and level of autonomic responsiveness. One possibility, suggested by the work of Mednick (19S8) , is that remote associative responses are anxietyreducing responses which gradually become highly practiced because they reduce tension. If a phenothiazine drug reduces anxiety it may in essence do for the individual what the remote associations did formerly; thus, under the drug condition less of these responses are needed to avoid anxiety arousal. This would also account for the increase in remote responses in the placebo group where an increasing anxiety level might stimulate increased use of low probability associates. Another possibility is that the drug affects associative processes primarily and that the reduction in autonomic reactivity is due to the suppression of primary-process material in awareness. A third possibility is that the phenothiazines affect associative processes and autonomic responses concurrently and that these parallel response decrements mutually reinforce each other over a period of time to produce more appropriate behavior. Certainly, more research designed to test these various alternatives will do much to identify the locus of phenothiazine drug action on a psychological level.
